Laboratory Related CRFs for Pharmacokinetics Study

 
MTN-027 Laboratory Related CRFs
 
Pharmacokinetics Specimens (PKS-1) - Enrollment, Day
28
Pharmacokinetics Specimens (PKD-1) - Days 1, 2, 3, 7, 14,
21, 29, 30, 31, 35)
Specimen Storage
HIV Results
HIV Confirmatory Results
Ring Collection and Insertion
Safety Laboratory Results
STI Test Results
 
Laboratory Related CRFs
Select if blood, vaginal fluid,
and rectal fluid samples for PK
were stored, not stored or not
collected
If not stored, specify why
There is no item 2 on the
Enrollment form because
there is no 0-hour blood draw
at enrollment
Collection times are
documented on the LDMS
tracking form
Item 12: Complete for those
participant who have
consented to provide rectal
fluid at this visit
 
Pharmacokinetics – Enrollment CRF
Select if the single-
time blood and
vaginal fluid for PK
were stored, not
stored or not
collected
If not stored,
specify why
 
 
Pharmacokinetics – Days 1-21, 29-35 CRF
Similar to the Enrollment PK
form, except the Day 28 form
includes the 0-hour blood draw
and cervical biopsy for PK and
PD items
 
If silver nitrate/monsels solution
is used to stop bleeding during
the collection of cervical
biopsies,  this should be noted
in the comments section to
better inform PK analyses
 
 
 
Pharmacokinetics – Day 28 CRF
Specimen Storage
form:
Completed at
Enrollment, Day 3,
Day 28 and Day 35
Documentation for:
Vaginal smear for
gram stain
Quantitative
vaginal culture
Vaginal swab for
biomarkers
Collection of the
used vaginal ring
and collection time
 
Specimen Storage (SS-1) CRF
Safety Laboratory Results
CRF: Complete at Enrollment
and at Day 28 and 35 Visits
Page 1 documents
Hemogram and Differential
If Severity is Grade 1 or
higher, it should be entered,
if below Grade 1 leave the
“Severity Grade” box blank
Record any AE Log Page #’s
associated with the lab
result
 
Safety Laboratory Results (SLR-1) CRF
Safety Laboratory
Results CRF page 2:
Documentation for
chemistries and
Dipstick UA results
 
Grade the severity of
the urine glucose
value according to the
“Proteinuria, random
collection” row of the
DAIDS Table V1.0
 
Safety Laboratory Results (SLR-2) CRF
Ring Collection and Insertion (RCI-1) CRF
Required on Day 28
to document ring
collection
 
Complete as needed
if an additional ring
is dispensed or a
ring is returned
during the study-
not expected
Ring Collection and Insertion (RCI-1) CRF
 
Item 1a: If the ring
was removed prior
to Day 28, indicate
the date that the
ring was last in
place
Item 4: If a ring was
inserted at this visit,
indicate the time
that the ring was
inserted in item 4a.
 
HIV Results CRF
Complete this form at
Day 35/Final Clinic Visit
and if indicated during
follow-up
 
If test is positive or
indeterminate,
complete the HIV
Confirmatory Results
CRF and document
product hold on PH-1
 
HIV Confirmatory Results CRF
Complete this form for
each visit where the
participant has a positive
or indeterminate EIA test
 
In Item 2, mark ‘pending’
if the participant’s final
HIV status is not clearly
known and update once
final status is determined
 
STI Results CRF
 
Complete this form, if indicated, to document
Vaginal Wet Prep, rapid Trich, GC/CT and syphilis
testing during follow up
 
If a test result(s) indicates that the participant
has a new (or increased severity) laboratory-
confirmed infection or diagnosis, this must be
recorded as an adverse experience on an
Adverse Experience (AE) Log
 
STI Results CRF
If vaginal wet prep
was performed but
not all assays were
completed, mark
“Not done/Not
collected” for each
uncompleted wet
prep assay
 
Slide Note
Embed
Share

This collection encompasses various CRFs related to laboratory procedures in the context of Pharmacokinetics for a study. It includes forms for enrollment, specimen storage, safety laboratory results, and specific days for sample collection. The CRFs detail the storage, collection, and documentation of specimens such as blood, vaginal fluid, rectal fluid, and cervical biopsies at different time points throughout the study. Safety laboratory results and specimen storage processes are also documented in the forms. These CRFs provide a comprehensive overview of the laboratory-related aspects of the study.

  • Laboratory
  • CRFs
  • Pharmacokinetics
  • Specimen Storage
  • Safety Results

Uploaded on Sep 10, 2024 | 1 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

E N D

Presentation Transcript


  1. MTN-027 Laboratory Related CRFs

  2. Laboratory Related CRFs Pharmacokinetics Specimens (PKS-1) - Enrollment, Day 28 Pharmacokinetics Specimens (PKD-1) - Days 1, 2, 3, 7, 14, 21, 29, 30, 31, 35) Specimen Storage HIV Results HIV Confirmatory Results Ring Collection and Insertion Safety Laboratory Results STI Test Results

  3. Pharmacokinetics Enrollment CRF Select if blood, vaginal fluid, and rectal fluid samples for PK were stored, not stored or not collected If not stored, specify why There is no item 2 on the Enrollment form because there is no 0-hour blood draw at enrollment Collection times are documented on the LDMS tracking form Item 12: Complete for those participant who have consented to provide rectal fluid at this visit

  4. Pharmacokinetics Days 1-21, 29-35 CRF Select if the single- time blood and vaginal fluid for PK were stored, not stored or not collected If not stored, specify why

  5. Pharmacokinetics Day 28 CRF Similar to the Enrollment PK form, except the Day 28 form includes the 0-hour blood draw and cervical biopsy for PK and PD items If silver nitrate/monsels solution is used to stop bleeding during the collection of cervical biopsies, this should be noted in the comments section to better inform PK analyses

  6. Specimen Storage (SS-1) CRF Specimen Storage form: Completed at Enrollment, Day 3, Day 28 and Day 35 Documentation for: Vaginal smear for gram stain Quantitative vaginal culture Vaginal swab for biomarkers Collection of the used vaginal ring and collection time

  7. Safety Laboratory Results (SLR-1) CRF Safety Laboratory Results CRF: Complete at Enrollment and at Day 28 and 35 Visits Page 1 documents Hemogram and Differential If Severity is Grade 1 or higher, it should be entered, if below Grade 1 leave the Severity Grade box blank Record any AE Log Page # s associated with the lab result

  8. Safety Laboratory Results (SLR-2) CRF Safety Laboratory Results CRF page 2: Documentation for chemistries and Dipstick UA results Grade the severity of the urine glucose value according to the Proteinuria, random collection row of the DAIDS Table V1.0

  9. Ring Collection and Insertion (RCI-1) CRF Required on Day 28 to document ring collection Complete as needed if an additional ring is dispensed or a ring is returned during the study- not expected

  10. Ring Collection and Insertion (RCI-1) CRF Item 1a: If the ring was removed prior to Day 28, indicate the date that the ring was last in place Item 4: If a ring was inserted at this visit, indicate the time that the ring was inserted in item 4a.

  11. HIV Results CRF Complete this form at Day 35/Final Clinic Visit and if indicated during follow-up If test is positive or indeterminate, complete the HIV Confirmatory Results CRF and document product hold on PH-1

  12. HIV Confirmatory Results CRF Complete this form for each visit where the participant has a positive or indeterminate EIA test In Item 2, mark pending if the participant s final HIV status is not clearly known and update once final status is determined

  13. STI Results CRF Complete this form, if indicated, to document Vaginal Wet Prep, rapid Trich, GC/CT and syphilis testing during follow up If a test result(s) indicates that the participant has a new (or increased severity) laboratory- confirmed infection or diagnosis, this must be recorded as an adverse experience on an Adverse Experience (AE) Log

  14. STI Results CRF If vaginal wet prep was performed but not all assays were completed, mark Not done/Not collected for each uncompleted wet prep assay

Related


More Related Content

giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#